|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ERYTHROMYCIN |
D10AF02 |
DE
|
POM
|
02-06-2021 |
|
|
VALID
|
|
FEDRATINIB |
L01XE57 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
OFATUMUMAB |
L04AG12 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
REMIMAZOLAM |
N05CD14 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
SAMARIUM (153SM) LEXIDRONAM |
V10BX02 |
DE
|
POM
|
02-06-2021 |
|
|
VALID
|
|
SELPERCATINIB |
L01EX22 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
TUCATINIB |
L01EH03 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
NOSCAPINE |
R05DA07 |
DE
|
POM
|
30-06-2021 |
|
|
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
DOSTARLIMAB |
L01FF07 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
ELIVALDOGENE AUTOTEMCEL |
N07XX00 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
TECHNETIUM (99MTC) ANTIGRANULOCYTE ANTIBODY |
V09HA03 |
DE
|
POM
|
08-10-2021 |
|
|
VALID
|
|
TECHNETIUM (99MTC) DEPREOTIDE |
V09IA05 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
TIRBANIBULIN |
D06BX03 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
VERICIGUAT |
C01DX22 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
DE
|
Not authorised
|
11-10-2021 |
|
|
VALID
|
|
VOSORITIDE |
M05BX07 |
DE
|
Not authorised
|
11-10-2021 |
|
|
VALID
|
|
COLECALCIFEROL |
A11CC05 |
DE
|
POM
|
18-10-2021 |
DE/H/3675/001/ |
30-09-2014 |
VALID
|
|
IMATINIB |
L01EA01 |
DE
|
POM
|
18-10-2021 |
DE/H/3814/002/ |
23-04-2015 |
VALID
|
|
SIPONIMOD |
L04AE03 |
DE
|
POM
|
18-10-2021 |
|
|
VALID
|
|
CEFTAROLINE FOSAMIL |
J01DI02 |
DE
|
POM
|
19-10-2021 |
|
|
VALID
|
|
DICLOFENAC |
M01AB05 |
DE
|
POM + Exemption
|
28-10-2021 |
DE/H/1087/001/MR |
07-11-2008 |
VALID
|
|
BENPROPERINE |
R05DB02 |
DE
|
POM
|
25-01-2022 |
|
|
VALID
|
|
TAFASITAMAB |
L01FX12 |
DE
|
POM
|
27-01-2022 |
|
|
VALID
|
|
GLUCARPIDASE |
V03AF09 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
SAPROPTERIN |
A16AX07 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
SITAGLIPTIN |
A10BH01 |
DE
|
POM
|
29-03-2022 |
|
|
VALID
|
|
ABROCITINIB |
D11AH08 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
ARTESUNATE |
P01BE03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
DAUNORUBICIN |
L01DB02 |
DE
|
POM
|
25-04-2022 |
DE/H/2810/001/ |
29-07-2014 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
